本文へ移動
cccskills

「fusion」の検索結果

379 件 ・ 関連度順

概要と使いどころ

Adapt and convert AI prompts between different models and platforms. Translates between Midjourney, Flux, Leonardo AI, DALL-E, Sora, Imagen, Stable Diffusion, Adobe Firefly, Ideogram, and more. Handles syntax differences, parameter mapping, and model-specific optimizations. Use when user says "adapt prompt", "convert prompt", "translate prompt", "port to flux", "midjourney to dall-e", or "change model".

日本語の概要は準備中です。原文の説明を表示しています。

gabrielmoreira/agent-skills-mirror192026年10月12日 更新

為使用者產生高品質的 AI 生圖、生影片、生音樂提示詞,並在需要時透過瀏覽器自動化實際送到目標平台。涵蓋 OiiOii、Kling 3.0/O-series、Seedance 2.0/2.5、Suno v5.5、Seedream 5.0/4.0、Vidu Q3、Midjourney V8.1、Flux 1.1 Pro / Kontext、Runway Gen-4.5 / Aleph、Google Veo 3.1、Ideogram 3、Nano Banana Pro、Stable Diffusion 3.5(⚠️ OpenAI Sora 2 已於 2026-04-26 停運,API 撐到 2026-09-24,預設改推 Runway/Veo/Kling)。只要使用者提到「AI 生圖」「AI 影片」「AI 音樂」「做 MV」「做 storyboard」「寫 prompt 給 XXX」「我想用 Kling/Suno/Midjourney/Runway/Veo...」「幫我操作 OiiOii / 即夢 / 可靈」「txt2img / img2video / 文生圖 / 文生影片 / 圖生影片」「角色一致性」「多鏡頭分鏡」「運鏡」「結果有瑕疵 / 不夠精緻 / 怎麼修」,或任何跟上述平台或影像/影片/音樂生成工作流相關的任務,都要用這個 skill。即使他們沒講明平台,只要任務是要餵給某個生成模型的 prompt,就用這個 skill 幫他們選對的平台、寫對的格式。

日本語の概要は準備中です。原文の説明を表示しています。

gabrielmoreira/agent-skills-mirror192026年10月12日 更新

Ultimate AI prompt database and builder with 2,500+ curated prompts across 19 categories and 17 AI models (Midjourney, Flux, Leonardo AI, DALL-E, Sora, Imagen, Mystic, Stable Diffusion, Ideogram, Adobe Firefly, and more). Search, build, enhance, and adapt prompts for image generation, video creation, text, and meta-prompt generators. Use when user says "prompt", "find a prompt", "build a prompt", "enhance my prompt", "adapt this prompt", "prompt library", "image prompt", "video prompt", "midjourney prompt", "flux prompt", or any AI prompt engineering task. Do NOT use for terminal/CLI prompts, JavaScript prompt() dialogs, user input prompts, or bash prompt customization.

日本語の概要は準備中です。原文の説明を表示しています。

gabrielmoreira/agent-skills-mirror192026年10月12日 更新

Produce a UGC-style talking-head video ad end to end on the MaxFusion MCP — research the product with user-supplied competitor leads, tear down 5 competitor Meta ads and 5 organic TikToks, write a pain-driven script that sounds like a person talking (never like an ad), reverse-prompt a rights-clean photoreal actor from a user-supplied reference photo, generate two chained 10-second Gemini Omni clips that play as one continuous take, and ship a single seamless 9:16 MP4. Use whenever the user wants a UGC ad, a talking-head ad, an ad for an app or product, mentions Omni or Gemini Omni Flash, drops an actor photo and asks for a video ad, or says anything like "make me some UGC", "let's make ads for X", or "another variation". Built for Claude Code (local ffmpeg); degrades to Claude app with documented fallbacks.

日本語の概要は準備中です。原文の説明を表示しています。

MegaTroll222/OMNI-UGC-AD-FACTORY162026年7月18日 更新

对 profiling 数据(kernel_details.csv / trace_view.json / step_trace_time.csv)做统一分析: 5 层递进管道(analyze_trace.py)+ baseline/优化后 kernel diff(compare_traces.py),输出 瓶颈诊断、算子执行序、可融合候选与 P0-P2 方向建议。输入统一来自 profiling-collect。 只要用户有 profiling 产出并问"为什么慢/瓶颈在哪/优化前后差多少/往哪个方向",都用本技能;采集走 profiling-collect,方案选档走 dit-perf-opt,实现/并行/基准走 pattern-dev/dit-parallel-opt/benchmark-dev——本技能只做诊断与方向。 由 model-auto-optimization 的 S1(融合分析)/S3(并行)阶段调用,亦由 dev-workflow 的分析阶段指引加载。 融合机会候选只做**识别**;候选的**边界与收益判定**(能不能融成一个单元、融多大、值不值)交 `fusion-scope-analyze`(本技能的辅助技能)——本技能不判融合边界。

日本語の概要は準備中です。原文の説明を表示しています。

Ascend/MindIE-SD152026年10月12日 更新

融合单元的范围判定与收益前置评估:判定「哪些计算该被融进同一个融合单元、边界画在哪、 融了值不值」。结构侧按融合单元构造规则切边界——函数边界即候选组;FA(含 BSA 等变种)为 禁融锚点;以 norm / rope / FA 为分界分区,全 Vec 区域优先试融;区域内有 Cube 时以 Cube 为 首算子向后包裹 Vec(Σvec 小于 cube 或遇下一 Cube 封口);一轮之后纯 Vector 单元之间再迭代; MLP / MoE 以矩阵乘族(MatMul / BatchMatMul / GroupedMatmul)为界;若该段计算已由单个 融合算子承载,按规则 6 先确认载体是否已生效(不重复建单元)。 收益侧按计算单元利用率判型(memory_bound、*_vec|mac|mte2|mte3_ratio、cube_utilization), 叠加带宽下限 / 区域占比 / 天花板法 / 地板先行 / Amdahl 传导校验给出 go/no-go。 当用户问「这几个算子能不能融成一个」「融合边界画在哪」「融多大范围」「融了值不值得」, 或 profiling-analyze 给出融合机会候选需要定范围与收益时使用;即使用户只说「这条链要不要 合成一个 kernel」「这里能不能省一次读写」也应触发。 **已经做完、实测收益却打平或为负时同样触发**——此时的任务不是接受"融合无收益", 而是按事后复核做**等功忙计数对照**归因,并在缺陷落在融合核自身时**升级 operator-dev**。 边界:只出「融合单元草案 + 收益判定 + 否决理由」。不做采纳与选点(dit-perf-opt 依收益选 top 并派活)、不做采集与瓶颈定位(profiling-collect / profiling-analyze)、不写 kernel、不写 pattern、 不做使能与并行选型、不定义验收标准(引 accuracy-gate / perf-gate)。 由 profiling-analyze(融合机会候选)与 operator-dev(实现前的收益评估)调用。

日本語の概要は準備中です。原文の説明を表示しています。

Ascend/MindIE-SD152026年10月12日 更新

Inspect scoped Autodesk data, compare versioned BOMs, and prepare ownership-aware drafts or approved custom-property changes. Not for implicit PLM release, membership changes or CAD geometry editing.

日本語の概要は準備中です。原文の説明を表示しています。

openai/community-plugins152026年10月13日 更新

Designs novel molecules using REINVENT 4 (de novo, scaffold decoration, linker design, R-group, molecular optimization), MolMIM, Diffusion-based generators (DiGress, DiffSMol), and JT-VAE with explicit handling of multi-parameter optimization (MPO), goal-directed scoring functions, transfer/reinforcement/curriculum learning, synthetic accessibility scoring, and chemical space exploration vs exploitation. Use when designing new chemical matter against a target, decorating a scaffold, linking fragments, or optimizing a hit for multiple ADMET / activity properties simultaneously.

日本語の概要は準備中です。原文の説明を表示しています。

lilinji/GeneTind-Life-Skills142026年8月21日 更新

Profiles RNA-binding protein targets without antibody or UV crosslinking using STAMP (APOBEC1-RBP fusion, C-to-U editing), scSTAMP (single-cell), TRIBE/HyperTRIBE (ADAR-RBP, A-to-I editing), DART-seq (APOBEC1-YTH for m6A), or Bullseye/SAILOR edit-site detection pipelines. Use when antibody is unavailable or specificity is doubtful, when single-cell RBP profiling is needed (scSTAMP), or when in vivo RBP profiling without UV is preferred.

日本語の概要は準備中です。原文の説明を表示しています。

lilinji/GeneTind-Life-Skills142026年8月21日 更新

Map N6-methyladenosine (m6A) RNA modifications at single-nucleotide resolution using miCLIP (Linder 2015), miCLIP2 + m6Aboost machine learning (Kortel 2021), GLORI (Liu 2023, antibody-free chemical conversion), DART-seq (Meyer 2019, APOBEC1-YTH fusion), m6Anet (nanopore direct RNA), or MeRIP-seq with calibration. Use when distinguishing antibody-based from antibody-free m6A detection methods, applying the DRACH motif constraint, reconciling cross-method disagreements (DART 44% in DRACH vs GLORI), or detecting m6Am at the cap.

日本語の概要は準備中です。原文の説明を表示しています。

lilinji/GeneTind-Life-Skills142026年8月21日 更新

Resolve the architecture of focal oncogene amplifications — extrachromosomal DNA (ecDNA), breakage-fusion-bridge (BFB) cycles, homogeneously staining regions (HSR), and linear amplification — from whole-genome sequencing with AmpliconArchitect, the AmpliconSuite pipeline, and AmpliconClassifier. Covers copy-number seed selection, breakpoint-graph reconstruction, balanced-flow optimization, ecDNA classification, and the limits of depth-only amplification calls. Use when a focal amplification needs structural characterization, when distinguishing ecDNA from chromosomal amplification, suspecting ecDNA-driven oncogene amplification or therapy resistance, or selecting copy-number seeds for amplicon reconstruction.

日本語の概要は準備中です。原文の説明を表示しています。

lilinji/GeneTind-Life-Skills142026年8月21日 更新

Performs gene-level association from GWAS summary statistics via genetically predicted tissue expression using FUSION, PrediXcan, S-PrediXcan, S-MultiXcan, UTMOST, MOSTWAS, kTWAS, EpiXcan, TIGAR-V2, and probabilistic fine-mapping with FOCUS and MA-FOCUS. Use when running TWAS from GWAS sumstats, prioritising candidate causal genes from a GWAS lead locus, picking single-tissue vs cross-tissue models, identifying LD-induced TWAS false positives, choosing ancestry-matched prediction weights, fine-mapping co-regulated TWAS hits, or triangulating TWAS with cis-eQTL Mendelian randomization and colocalization to nominate a causal gene.

日本語の概要は準備中です。原文の説明を表示しています。

lilinji/GeneTind-Life-Skills142026年8月21日 更新

bindcraft

無料

End-to-end binder design using BindCraft hallucination. Use this skill when: (1) Designing protein binders with built-in AF2 validation, (2) Running production-quality binder campaigns, (3) Using different design protocols (fast, default, slow), (4) Need joint backbone and sequence optimization, (5) Want high experimental success rate. For backbone-only generation, use rfdiffusion. For QC thresholds, use protein-qc. For tool selection guidance, use binder-design.

日本語の概要は準備中です。原文の説明を表示しています。

lilinji/GeneTind-Life-Skills142026年8月21日 更新

qa

無料

Use after code changes, before releases, or when testing features - runs the right level of QA based on what changed

日本語の概要は準備中です。原文の説明を表示しています。

karloscodes/fusionaly-oss142026年10月11日 更新

Use when building Grafana dashboards backed by Prometheus, Loki, or Tempo, designing PromQL/LogQL queries, wiring template variables, setting alert rules, building SLO dashboards, or maintaining dashboards as code. Triggers: rate() vs increase() confusion, irate vs rate, label_replace, recording rules, alerting rule expressions, multi-dimensional template variables, ad-hoc filters, dashboard JSON model, provisioning via Terraform/grafonnet, p99 / histogram_quantile usage. NOT for Datadog/New Relic dashboards (vendor-specific), Grafana plugin development, or Loki ingestion pipeline tuning.

日本語の概要は準備中です。原文の説明を表示しています。

curiositech/windags-skills132026年10月12日 更新

Advanced CV for infrastructure inspection including forest fire detection, wildfire precondition assessment, roof inspection, hail damage analysis, thermal imaging, and 3D Gaussian Splatting reconstruction. Expert in multi-modal detection, insurance risk modeling, and reinsurance data pipelines. Activate on "fire detection", "wildfire risk", "roof inspection", "hail damage", "thermal analysis", "Gaussian Splatting", "3DGS", "insurance inspection", "defensible space", "property assessment", "catastrophe modeling", "NDVI", "fuel load". NOT for general drone flight control, SLAM, path planning, or sensor fusion (use drone-cv-expert), GPU shader development (use metal-shader-expert), or generic object detection without inspection context (use clip-aware-embeddings).

日本語の概要は準備中です。原文の説明を表示しています。

curiositech/windags-skills132026年10月12日 更新

Use when applying Cloudflare D1 migrations, fighting Supabase migration history vs SQL execution, choosing direct psql over CLI, designing idempotent migrations, debugging schema drift between local and remote, or recovering after a half-applied migration. Triggers: supabase migration repair instructions appearing, table missing after "applied" status, "Tenant or user not found" when running psql, --remote vs --local D1 confusion, NOT NULL on a populated column, foreign key constraint failures, drift between staging and prod schemas. NOT for Mongo/document migrations, ORM-managed migrations specifically (Prisma/Drizzle have their own conventions), or pure data backfills.

日本語の概要は準備中です。原文の説明を表示しています。

curiositech/windags-skills132026年10月12日 更新

Use when designing a background-job system, choosing between BullMQ / Sidekiq / RQ / Temporal / SQS, deciding queue-vs-workflow, sizing concurrency vs rate limits, building dead-letter queues, or making handlers idempotent. Triggers: jobs running twice on retry, lost jobs after worker crash, DLQ filling up, Redis OOM from job backlog, exactly-once requested, "do we need Temporal?", visibility timeout / lockDuration confusion, exponential backoff vs jitter, fan-out fan-in workflows. NOT for outbound webhook publishing (different concerns), receiver-side webhook handling (different concerns), event-streaming/Kafka topology, or in-process async (event loop only).

日本語の概要は準備中です。原文の説明を表示しています。

curiositech/windags-skills132026年10月12日 更新

This skill checks for contraindications or sources of inaccuracy that may affect continuous glucose monitoring (CGM) reliability in hospitalized adults. It is triggered when clinicians ask, “Are there factors that could make CGM unreliable?” or when assessing for skin infection, hypoperfusion, hypovolemia, vasoactive/pressor therapy, or medications such as acetaminophen >4 g/day, dopamine, vitamin C, or hydroxyurea.

日本語の概要は準備中です。原文の説明を表示しています。

dromlakhani/MD2SKILL132026年10月5日 更新

Recommends continuous subcutaneous insulin infusion (CSII) over multiple daily injections (MDI) for adults with type 1 diabetes who have achieved their A1C goal but experience severe hypoglycemia or high glucose variability, provided the patient and caregivers are willing and able to use the device. Consider CSII when clinicians hear 'A1C is at goal but patient has severe lows or glucose swings' or think 'pump for hypoglycemia-prone controlled T1DM'.

日本語の概要は準備中です。原文の説明を表示しています。

dromlakhani/MD2SKILL132026年10月5日 更新

This skill reassesses the insulin plan when discontinuing continuous subcutaneous insulin infusion (CSII) and transitioning to multiple daily injections (MDI). It is triggered by phrases such as 'Review planned basal-bolus regimen after pump' and 'Confirm MDI dose calculations and schedule'.

日本語の概要は準備中です。原文の説明を表示しています。

dromlakhani/MD2SKILL132026年10月5日 更新

Suggests that adults with type 1 or type 2 diabetes using continuous subcutaneous insulin infusion (CSII) and continuous glucose monitoring (CGM) receive education, training, and ongoing support to achieve and maintain individualized glycemic goals. Trigger phrases include: 'Patient on pump plus CGM, arrange education' and 'Ensure CSII+CGM users get training and support'.

日本語の概要は準備中です。原文の説明を表示しています。

dromlakhani/MD2SKILL132026年10月5日 更新

This skill guides clinicians to reassess glucose monitoring frequency when discontinuing continuous subcutaneous insulin infusion (CSII) or transitioning to multiple daily injections (MDI). It is triggered by phrases such as 'Plan for glucose monitoring after pump stop' or 'Determine SMBG/CGM frequency post-pump' to ensure individualized glycemic goals are met.

日本語の概要は準備中です。原文の説明を表示しています。

dromlakhani/MD2SKILL132026年10月5日 更新

Suggests continuous subcutaneous insulin infusion (CSII) for adults with type 1 diabetes mellitus who desire increased insulin delivery flexibility or improved treatment satisfaction and are capable of using the device. Clinical triggers include statements such as 'Patient wants more lifestyle flexibility with insulin' or 'Consider pump for improved satisfaction in T1DM'.

日本語の概要は準備中です。原文の説明を表示しています。

dromlakhani/MD2SKILL132026年10月5日 更新